Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating)'s share price reached a new 52-week low on Thursday . The company traded as low as $49.81 and last traded at $49.81, with a volume of 18 shares traded. The stock had previously closed at $50.55.
Analyst Ratings Changes
Separately, DA Davidson reaffirmed a "neutral" rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, August 9th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $80.50.
Get Prestige Consumer Healthcare alerts:Prestige Consumer Healthcare Stock Down 0.8 %
The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.23 and a current ratio of 2.09. The firm has a fifty day moving average price of $55.14 and a 200 day moving average price of $55.41. The firm has a market capitalization of $2.50 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 1.50 and a beta of 0.55.
Institutional Trading of Prestige Consumer Healthcare
Several hedge funds have recently modified their holdings of PBH. BlackRock Inc. increased its stake in Prestige Consumer Healthcare by 12.4% in the 1st quarter. BlackRock Inc. now owns 9,115,718 shares of the company's stock valued at $482,584,000 after purchasing an additional 1,004,337 shares in the last quarter. Vanguard Group Inc. increased its stake in Prestige Consumer Healthcare by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 5,559,553 shares of the company's stock valued at $294,322,000 after purchasing an additional 59,740 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Prestige Consumer Healthcare by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,448,246 shares of the company's stock valued at $182,552,000 after purchasing an additional 12,790 shares in the last quarter. State Street Corp increased its stake in Prestige Consumer Healthcare by 4.9% in the 2nd quarter. State Street Corp now owns 1,921,456 shares of the company's stock valued at $112,982,000 after purchasing an additional 89,131 shares in the last quarter. Finally, Macquarie Group Ltd. increased its stake in Prestige Consumer Healthcare by 4.4% in the 2nd quarter. Macquarie Group Ltd. now owns 1,887,479 shares of the company's stock valued at $110,984,000 after purchasing an additional 79,519 shares in the last quarter. 99.37% of the stock is owned by institutional investors and hedge funds.About Prestige Consumer Healthcare
(Get Rating)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Featured Stories
- Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.